re e- tender for procurement of some drug items listed under table-a, for two years from the date of aoc , recombinant anti hemophilic factor viii 1000 iu. / vial , recombinant anti hemophilic factor viii 250 iu. / vial , important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender. 2. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 3. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi ( b ) in case of sole manufacturer / importer ( i.e. proprietary in nature ) . 4. if the item ( s ) under sole manufacturer / importer is ( are ) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item ( s ) proprietary in nature, otherwise their item ( s ) will be blocked in the smis. 5. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f ( y ) , dated 07.06.2022 issued from finance department audit branch ( group t ) .